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Catalog of Teratogenic Agents (3rd Edn).
T. H. SHEPARD (1980). London: Johns
Hopkins Univ. Press. 410 pp. £15-75.
As in previous editions, theinformation has
been obtained using a computer programme,
and the print-out has not been type-set. The
author points out the savings in cost, but the
presentation is unattractive, and it is for-
tunate that the book is a reference source for
specific items and need not be read as a
whole.
This latest edition contains an additional
600 items, with a thorough coverage of the
Japanese and Russian literature. There are
both subject and author indices and the
material is not restricted to specific chemicals
but, for example, includes references to the
effects of vaccines, viruses and dietary
deficiencies. Inside the front and back covers
there is also a useful table comparing the
timing of embryonic and foetal development
in man and experimental animals. Overall,
the book can be recommended as an ex-
tremely useful source of information on
teratogenic agents.
A. W. CRAIG
Tumor Antigenicity and Approaches to
Tumor Immunotherapy. D. W. WEISS
(1980). Berlin, Heidelberg, New York:
Springer-Verlag. 83 pp. $17-20.
The prospects of immunotherapy for
clinical cancer have been kept bright for
almost a century, not by the glow ofgathering
success but by the floodlight of promotion,
iteration, promise and pretence that the
seductive notion has inclined us to indulge.
Now that the interim results of many
hundreds of clinical trials are emerging, it is
seen that the impressive vessel of ideas has,
very largely, foundered in the cancer wards.
To the disappointment of many clinical
oncologists, who have acted on recom-
mendations from laboratory-animal data of
questionable clinical relevance, has been
added a streak of indignation; even tumour
immunologists are confessing to low spirits.
The fortunes of applied tumour immunology
are evidently on a depression oftheir familiar
undulation. Morale has to be restored, the
image of novelty and excitement retouched,
support retained, and a basis for rededication
supplied. Professor Weiss here provides a
strategy for redeployment.
The opening sentence of the text proclaims
the dilemma: "The central hypothesis under-
lying all attempts at immunological inter-
vention in neoplastic disease is today in
danger of falling". The quotation from
Nachman of Bratzlav which introduces the
work ("It is forbidden to despair") betrays a
mood which had been better not generated
by precocious application of inflated theory.
In the last 20 years or so the scope for
theoretical immunotherapy has been in-
creasingly widened by striking advances in
general immunology. The author, fitted by
long experience and remarkable erudition in
the field, by a facility for scrupulously
phrased expression, and by a brilliance of
optimistic imagination, has fashioned from
these advances a phantasmagoria of possible
clinical applications. The hazards and limita-
tions ofthe more daring manoeuvres, such as
the regional perfusion of allogeneic lympho-
cytes, grown up and sensitized to theoretical
TSA (or TAA) in vitro, are frankly faced, only
to be given a perhaps too confident promise
of control. Enhancement, once treated as a
hazard of immunotherapy, is recruited as an
advantage to combined therapy: "neoplastic
cells stimulated to proliferation can become
more susceptible targets for concordant
cytotoxic treatments".
Many visions familiar in the history of the
topic are re-projected with a polish from the
modern context and the author's style:
cytotoxic agents being made to "home in" to
a tumour on the backs of (now) monoclonal
antibodies; the concept of cancer as a
"neoplastic parasite"; prophylactic "vaccina-
tion" against some cancers; future discovery
of oncogenic viruses in man; the bugbear of
"escape" from "potential immune surveil-
lance"; and the spectre of "idiosyncratic host
immune failure".
If the intensity of optimism and the zeal of
intellectual probing invite reservations and a